{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicfap3t6m3gsx2a3vcpto4wsnf7nb4jvvzsgmkqmv7z4nsfbjh22m",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mebcxi2o4qw2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreig2abycxdfttxv7xhkfpykwfzvpzfv67vta53efyb6i243z64gduu"
    },
    "mimeType": "image/jpeg",
    "size": 206376
  },
  "path": "/news/2026-02-drug-loberamisal-boost-recovery-hours.html",
  "publishedAt": "2026-02-07T05:30:01.000Z",
  "site": "https://medicalxpress.com",
  "tags": [
    "Cardiology"
  ],
  "textContent": "Stroke patients treated intravenously with loberamisal, a novel neuroprotective medication, daily for 10 days and starting within 48 hours of stroke symptoms, had better recovery than patients who received a placebo, according to a preliminary late-breaking science presentation at the American Stroke Association's International Stroke Conference 2026.",
  "title": "Stroke drug loberamisal may boost recovery when started within 48 hours"
}